First QiC Hepatitis C takes place at BASL conference
Healthcare professionals working to improve care for hepatitis C patients in the UK were honoured last week at the first Quality in Care (QiC) Hepatitis C awards.
Held September 16 at the British Association for the Study of the Liver (BASL) conference in Gateshead QiC Hepatitis C celebrated the work of eight projects working to improve hepatitis C prevention, diagnosis & testing, treatment pathways and patient support in the UK.
Winners included NHS Tayside for its work providing access to hepatitis C treatment for people who inject drugs and Dundee CHP for its work to improve outcomes for patients with blood borne virus in Dundee.
NHS, industry and the charitable sector collaborate to spread best practice in hepatitis C prevention, diagnosis, treatment and patient support
The first Quality in Care (QiC) Hepatitis C programme is now open for
entry to teams and individuals working within the field of hepatitis C.
Launched last week at the International Liver Congress in London, QiC
Hepatitis C recognises, rewards and shares good practice in hepatitis C
prevention, diagnosis & testing, treatment pathways and patient
support throughout the UK.
To support improved healthcare in this area, QiC Hepatitis C comprises
both an awards event and subsequent dissemination opportunities, and has
the endorsement, support and active participation of key stakeholders,
including the British Liver Trust, the Hepatitis C Trust, Bristol-Myers
Squibb and Gilead Sciences.